IRON — Disc Medicine Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Disc Medicine, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -71.9 | -46.8 | -76.4 | -109 | -212 |
| Depreciation | |||||
| Non-Cash Items | 10.1 | 2.36 | 5.82 | 12 | 28 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.86 | 2.13 | -2.95 | 3.23 | 3.53 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -59.7 | -42.3 | -73.5 | -93.9 | -180 |
| Capital Expenditures | -0.071 | -0.151 | -0.089 | -0.505 | -0.933 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.415 | — | — | -292 | -393 |
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 0.344 | -0.151 | -0.089 | -292 | -394 |
| Financing Cash Flow Items | 196 | 95.3 | 0 | -0.952 | 0.578 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 191 | 149 | 239 | 218 | 473 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 132 | 107 | 166 | -168 | -101 |